Biovest emerges from bankruptcy with new CEO
This article was originally published in Scrip
Executive Summary
Biovest International emerged from Chapter 11 bankruptcy reorganization with Carlos Santos as the company's new CEO to lead the transition from clinical development to commercial sales for the late-stage cancer vaccine BiovaxID.